106 related articles for article (PubMed ID: 28705614)
1. Tracing molecular and structural changes upon mucolysis with N-acetyl cysteine in human airway mucus.
Vukosavljevic B; Murgia X; Schwarzkopf K; Schaefer UF; Lehr CM; Windbergs M
Int J Pharm; 2017 Nov; 533(2):373-376. PubMed ID: 28705614
[TBL] [Abstract][Full Text] [Related]
2. Combining confocal Raman microscopy and freeze-drying for quantification of substance penetration into human skin.
Franzen L; Anderski J; Planz V; Kostka KH; Windbergs M
Exp Dermatol; 2014 Dec; 23(12):942-4. PubMed ID: 25219950
[TBL] [Abstract][Full Text] [Related]
3. Visualization of the structure of native human pulmonary mucus.
Meziu E; Koch M; Fleddermann J; Schwarzkopf K; Schneider M; Kraegeloh A
Int J Pharm; 2021 Mar; 597():120238. PubMed ID: 33540010
[TBL] [Abstract][Full Text] [Related]
4. Different macro- and micro-rheological properties of native porcine respiratory and intestinal mucus.
Bokkasam H; Ernst M; Guenther M; Wagner C; Schaefer UF; Lehr CM
Int J Pharm; 2016 Aug; 510(1):164-7. PubMed ID: 27311353
[TBL] [Abstract][Full Text] [Related]
5. Tensiometric and Phase Domain Behavior of Lung Surfactant on Mucus-like Viscoelastic Hydrogels.
Schenck DM; Fiegel J
ACS Appl Mater Interfaces; 2016 Mar; 8(9):5917-28. PubMed ID: 26894883
[TBL] [Abstract][Full Text] [Related]
6. Rheology of mucus and transepithelial potential difference: small airways versus trachea.
App EM; Zayas JG; King M
Eur Respir J; 1993 Jan; 6(1):67-75. PubMed ID: 8425597
[TBL] [Abstract][Full Text] [Related]
7. Exogenous surfactant therapy and mucus rheology in chronic obstructive airway diseases.
Banerjee R; Puniyani RR
J Biomater Appl; 2000 Jan; 14(3):243-72. PubMed ID: 10656543
[TBL] [Abstract][Full Text] [Related]
8. Comparative mucolytic studies on dithiothreitol, N-acetyl-cysteine and L-cysteine on human respiratory mucus in vitro and their effects on the rate of flow of mucus in the exposed trachea of the rat on topical application.
Lightowler JE; Lightowler NM
Arch Int Pharmacodyn Ther; 1971 Jan; 189(1):53-8. PubMed ID: 5130152
[No Abstract] [Full Text] [Related]
9. Micro- and macrorheology of mucus.
Lai SK; Wang YY; Wirtz D; Hanes J
Adv Drug Deliv Rev; 2009 Feb; 61(2):86-100. PubMed ID: 19166889
[TBL] [Abstract][Full Text] [Related]
10. Role of the physiochemical properties of mucus in the protection of the respiratory epithelium.
Girod S; Zahm JM; Plotkowski C; Beck G; Puchelle E
Eur Respir J; 1992 Apr; 5(4):477-87. PubMed ID: 1563506
[TBL] [Abstract][Full Text] [Related]
11. Clarithromycin and N-acetylcysteine co-spray-dried powders for pulmonary drug delivery: A focus on drug solubility.
Manniello MD; Del Gaudio P; Aquino RP; Russo P
Int J Pharm; 2017 Nov; 533(2):463-469. PubMed ID: 28377314
[TBL] [Abstract][Full Text] [Related]
12. Methods for ASL measurements and mucus transport rates in cell cultures.
Worthington EN; Tarran R
Methods Mol Biol; 2011; 742():77-92. PubMed ID: 21547727
[TBL] [Abstract][Full Text] [Related]
13. Thin-film measurements of airway surface liquid volume/composition and mucus transport rates in vitro.
Tarran R; Boucher RC
Methods Mol Med; 2002; 70():479-92. PubMed ID: 11917544
[No Abstract] [Full Text] [Related]
14. Thermo-physical properties of synthetic mucus for the study of airway clearance.
Lafforgue O; Bouguerra N; Poncet S; Seyssiecq I; Favier J; Elkoun S
J Biomed Mater Res A; 2017 Nov; 105(11):3025-3033. PubMed ID: 28758330
[TBL] [Abstract][Full Text] [Related]
15. Models using native tracheobronchial mucus in the context of pulmonary drug delivery research: Composition, structure and barrier properties.
Huck BC; Murgia X; Frisch S; Hittinger M; Hidalgo A; Loretz B; Lehr CM
Adv Drug Deliv Rev; 2022 Apr; 183():114141. PubMed ID: 35149123
[TBL] [Abstract][Full Text] [Related]
16. Property profiling of biosimilar mucus in a novel mucus-containing in vitro model for assessment of intestinal drug absorption.
Boegh M; Baldursdóttir SG; Müllertz A; Nielsen HM
Eur J Pharm Biopharm; 2014 Jul; 87(2):227-35. PubMed ID: 24413146
[TBL] [Abstract][Full Text] [Related]
17. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
18. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery.
Odziomek M; Sosnowski TR; Gradoń L
Int J Pharm; 2012 Aug; 433(1-2):51-9. PubMed ID: 22580211
[TBL] [Abstract][Full Text] [Related]
19. Effects of concentrated ambient particles on normal and hypersecretory airways in rats.
Harkema JR; Keeler G; Wagner J; Morishita M; Timm E; Hotchkiss J; Marsik F; Dvonch T; Kaminski N; Barr E
Res Rep Health Eff Inst; 2004 Aug; (120):1-68; discussion 69-79. PubMed ID: 15543855
[TBL] [Abstract][Full Text] [Related]
20. Dexamethasone and N-acetyl-cysteine attenuate Pseudomonas aeruginosa-induced mucus expression in human airways.
Sprenger L; Goldmann T; Vollmer E; Steffen A; Wollenberg B; Zabel P; Hauber HP
Pulm Pharmacol Ther; 2011 Apr; 24(2):232-9. PubMed ID: 21146625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
